Register Login

AVALON GLOBOCARE CORP. (ALBT)

SymbolALBT
NameAVALON GLOBOCARE CORP.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
Address4400 ROUTE 9 SOUTH,SUITE 3100, FREEHOLD, New Jersey, 07728, United States
Telephone+1 732 - 780-4400
Fax—
Email—
Websitehttps://www.avalon-globocare.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK—
Description

Avalon GloboCare Corp. (OTCQB: AVCO) is a global intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high impact, transformative cell-based technologies and their clinical applications, as well as healthcare facility management through its core platforms, namely Avalon Cell and Avalon Rehab.

Additional info from NASDAQ:
Avalon GloboCare Corp. (OTCQB: AVCO) is a global intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high impact, transformative cell-based technologies and their clinical applications, as well as healthcare facility management through its core platforms, namely Avalon Cell and Avalon Rehab.

2026-04-23 02:08

ALBT attributes changed: Attr: Fin_status N -> D;

Read more
2026-04-21 17:30

New Form 8-K/A - Avalon GloboCare Corp. <b>Filed:</b> 2026-04-21 <b>AccNo:</b> 0001213900-26-046208 <b>Size:</b> 361 KB <br />Item 9.01: Financial Statements and Exhibits

Read more
2026-04-21 12:30

(97% Neutral) AVALON GLOBOCARE CORP. (ALBT) Announces Business Combination

Read more
2026-04-21 12:30

Avalon Quantum AI teams up with Caylent and Amazon Web Services on Agentic AI Platform Development

Read more
2026-04-21 07:04

New Form EFFECT - Avalon GloboCare Corp. <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 9999999995-26-001253 <b>Size:</b> 1 KB

Read more
2026-04-20 18:10

New Form 424B3 - Avalon GloboCare Corp. <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001213900-26-045689 <b>Size:</b> 1 MB

Read more
2026-04-17 18:24

New Form ARS - Avalon GloboCare Corp. <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0001213900-26-045261 <b>Size:</b> 1 MB

Read more
2026-04-17 18:24

New Form DEFA14A - Avalon GloboCare Corp. <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0001213900-26-045260 <b>Size:</b> 2 MB

Read more
2026-04-08 18:05

New Form RW - Avalon GloboCare Corp. <b>Filed:</b> 2026-04-08 <b>AccNo:</b> 0001213900-26-041563 <b>Size:</b> 7 KB

Read more
2026-04-02 20:10

(99% Neutral) AVALON GLOBOCARE CORP. (ALBT) Files Form 8-K

Read more
Trial ID Title Phase Indication Status Start Date Completion Date Source
NCT03952923 CD19-CAR-T in B-cell Malignancies Patients Phase1 B-cell Malignancy Completed 2019-08-01 2021-03-31 ClinicalTrials.gov
Total clinical trials: 1
Product Name Type Development Stage Therapeutic Area Study Status Trial ID
CD19-CAR-T cells BIOLOGICAL Phase PHASE1 B-cell Malignancy COMPLETED NCT03952923
Total products: 1